Betoptic: Selective Ocular Hypertensive Control for Glaucoma Management - Evidence-Based Review

Product Description: Betoptic, known generically as betaxolol hydrochloride, is a topical ophthalmic solution classified as a cardioselective beta-1 adrenergic receptor blocking agent. It is formulated as a sterile, isotonic solution for lowering elevated intraocular pressure (IOP) in patients with chronic open-angle glaucoma and ocular hypertension. Unlike non-selective beta-blockers, Betoptic exhibits a preferential affinity for beta-1 receptors, which theoretically offers a distinct safety profile, particularly for patients with concurrent pulmonary conditions. It functions by reducing aqueous humor production, thereby mitigating the primary risk factor for glaucomatous optic nerve damage and visual field loss.